Indraprastha Medical Corporation Share Price

Indrapr.Medical

CMP as on 26-Nov-20 15:46

₹ 52.05
0.05 0.1%

Open

₹ 51.90

Turnover (lac)

₹ 48

Prev. Close

₹ 52.00

Day's Vol (shares)

₹ 92,103

Day's Range (₹)

₹ 51.60
₹ 52.40

CMP as on26-Nov-20 15:39

₹ 51.95
-0.05 -0.1%

Open

₹ 51.70

Turnover (lac)

₹ 3

Prev. Close

₹ 52.00

Day's Vol (shares)

₹ 11,682

Day's Range

₹ 51.60
₹ 52.30

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Nov-2020 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th November, 2020, inter-alia to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2020. This is for your information and record. The Board of Directors of the Company, at their meeting held on 10th November, 2020, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2020. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2020, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 12 noon and ended at 03.15 p.m. This is for your information and record. (As Per BSE Announcement dated on 10.11.2020)
Board Meeting - 14-Aug-2020 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 24th August, 2020, to consider and approve, the unaudited financial results for the quarter ended 30th June, 2020. This is for your information and record. Dear Sir, This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 24th August, 2020 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-audited Financial results of the Company for the quarter ended 30th June 2020. 2. Appointment of Ms. Sangita Reddy as an Additional Director 3. Appointment of Mr. Priya Ranjan (ACS - 13826) as Company Secretary & Compliance Officer The Board meeting started at 3:00 p.m. and ended at 6:00 p.m. This is for your information and record. (AS Per BSE Announcement Dated on 24.08.2020)
Board Meeting - 14-May-2020 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Saturday, 23rd May, 2020, inter alia to consider and approve, the audited financial results for the quarter/ year ended 31st March, 2020. This is for your information and record. This is to inform that the Board of Directors of the Company has, at its meeting held on Saturday, 23rd May, 2020 (i.e. today), inter-alia, considered and approved :- (a) Audited Financial Results for the quarter and financial year ended 31st March, 2020, along with a copy of the Audit Report by the Statutory Auditors of the Company; (b) A declaration by CFO confirming that the Auditors have given an Unmodified Opinion on the Annual Audited Financial Results of the Company for the financial year ended 31st March 2020, as required under second proviso to regulation 33(3)(d) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015; This is to inform that the Board of Directors of the Company has, at its meeting held on Saturday, 23rd May, 2020 (i.e. today), inter-alia, considered and approved the following items: Re-appointed Dr. Arun Rai (DIN : 07159822 ) as Independent Director of the Company, for a period of 5 consecutive years effective from 26th May, 2020 to 25th May, 2025, subject to the approval of the shareholders of the Company. Appointed Dr. Menaka Guruswamy (DIN : 0008742679) as Independent Woman Director of the Company, for a period of 5 consecutive years effective from 23rd May, 2020 to 22nd May, 2025, subject to the approval of the shareholders of the Company. (As Per BSE Announcement Dated on 23/05/2020)
Board Meeting - 10-Jan-2020 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 3rd February, 2020, to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2019. This is for your information and record. Dear Sir, The Board of Directors of the Company, at their meeting held on 3rd February, 2020, have approved the un-audited financial results for the quarter and nine months ended 31st December, 2019. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2019, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 2.30 p.m. and ended at 4.15 p.m. This is for your information and record. (As Per BSE Announcement Dated on 03/02/2020)